E. Gerald Kay

2022

In 2022, E. Gerald Kay earned a total compensation of $286.4K as Executive Chairman and President at Integrated Biopharma.

Compensation breakdown

Option Awards$33,651
Salary$215,693
Other$37,036
Total$286,380

Kay received $215.7K in salary, accounting for 75% of the total pay in 2022.

Kay also received $33.7K in option awards and $37K in other compensation.

Rankings

In 2022, E. Gerald Kay's compensation ranked 5,143rd out of 5,760 executives tracked by ExecPay. In other words, Kay earned more than 10.7% of executives.

ClassificationRankingPercentile
All
5,143
out of 5,760
11th
Division
Manufacturing
2,825
out of 3,136
10th
Major group
Chemicals And Allied Products
1,314
out of 1,422
8th
Industry group
Drugs
1,235
out of 1,323
7th
Industry
Pharmaceutical Preparations
902
out of 969
7th
Source: SEC filing on October 27, 2023.

Kay's colleagues

We found four more compensation records of executives who worked with E. Gerald Kay at Integrated Biopharma in 2022.

2022

Dina Masi

Integrated Biopharma

Chief Financial Officer

2022

EGerald Kay

Integrated Biopharma

Chairman

2022

Riva Sheppard

Integrated Biopharma

Chief Executive Officer

2022

Christina Kay

Integrated Biopharma

Chief Executive Officer

News

You may also like